Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 15,187

Document Document Title
WO/2021/070152A1
The present invention relates to novel coumarin glyoxylates, a process for their preparation and their use as photoinitiators in photopolymerization compositions. The invention also concerns a process for the photopolymerization of compo...  
WO/2021/068501A1
Provided is a method for synthesizing myricetin, the method comprising the following steps: adding an alkaline solution to an aqueous solution of dihydromyricetin, and after the addition is completed, heating under a reflux state; adding...  
WO/2021/068952A1
A structurally novel benzodihydropyran compound targeting AKR1C3 enzyme (aldo-keto reductase 1C3). In particular, disclosed is a compound represented by formula (II) or a pharmaceutically acceptable salt or isomer thereof.  
WO/2021/064189A2
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them hig...  
WO/2021/066435A1
The present invention relates to a compound for an organic electric element, an organic electric element using same, and an electronic device comprising the organic electric element. According to the present invention, an organic electri...  
WO/2021/067627A1
Methods for converting mixtures of anthocyanins occurring in fruit or vegetable juice or extract into particular anthocyanin molecules having desirable colorant properties are provided herein. The method of the present disclosure can be ...  
WO/2021/062555A1
Topical formulations comprising one or more cannabinoids, one or more terpenes, and one or more flavonoids; and methods and uses thereof for the treatment of an integumentary wound, wherein the one or more cannabinoids comprise tetrahydr...  
WO/2021/062561A1
There is provided a method for cultivating and harvesting cannabis plants, comprising: cultivating a batch of a plurality of cannabis plants in a grow area, processing plant material from a portion of the plurality of cannabis plants in ...  
WO/2021/062557A1
This disclosure relates generally to cannabinoid derivatives having the formula (I), wherein R4 is hydrogen, -C(Q1)N(R4a)(R4b) or -C(R4J)(R4k)N(R4e)C(0)R4f, R6 is hydrogen, -C(Q2)N(R6a)(R6b) or -C(R6J)(R6k)N(R6e)C(0)R6f, provided that R6...  
WO/2021/062482A1
The invention relates to compounds that have antiviral activity, particularly 4-oxochromane derivatives that have antiviral activity against viruses of the Family Flaviviridae. Methods of treating viruses with the 4-oxochromane compounds...  
WO/2021/060276A1
Provided, inter alia, is a fluorinating agent that can selectively produce a monofluorination product through preferential synthesis of the monofluorination product over a difluorination product, in a fluorination reaction in which a flu...  
WO/2021/060691A1
The present invention provides type I crystals, type II crystals, type III crystals, and type IV crystals which are novel crystalline forms of 2-(2,5-difluorophenyl)-3-carboxy-7-chloro-(4H)-4-benzopyrano ne. In particular, the type IV cr...  
WO/2021/054714A1
The present application provides: a heterocyclic compound capable of significantly improving the lifespan, efficiency, electrochemical stability, and thermal stability of an organic light-emitting device; and an organic light-emitting de...  
WO/2021/053205A1
The present invention relates to chromen-4-one derivatives comprising a quaternary group, and to associated multi-salts, solvates, prodrugs and pharmaceutical compositions. The present invention also relates to the use of such compounds ...  
WO/2021/046630A1
A process for producing THC-O-acetate using a succession of distillation, salting-out assisted liquid-liquid extractions (SALLEs), and solvent recovery techniques. Tetrahydrocannabinol (THC) in cannabis oil dissolved in hexane reacts wit...  
WO/2021/015583A3
The present invention relates to a method for preparation of soybean leaves having a high content of an isoflavone derivative in a dark condition and soybean leaves having a high content of an isoflavone derivative prepared thereby. Spec...  
WO/2021/046628A1
A stable medicinal cannabidiol composition for use in oral delivery, the composition comprising synthetic cannabidiol (CBD) having a purity of at least 99.8 %, preferably at least 99.9 %, together with beta-caryophyllene (BCP) which func...  
WO/2021/046640A1
The present disclosure relates to new cannabinoid derivatives and precursors and catalytic asymmetric processes for their preparation. The disclosure also relates to pharmaceutical compositions and pharmaceutical and analytical uses of t...  
WO/2021/046636A1
The present disclosure relates to new cannabinoid derivatives and precursors and processes for their preparation. The disclosure also relates to pharmaceutical and analytical uses of the new cannabinoid derivatives.  
WO/2021/050449A1
Provided herein are compositions and methods of ameliorating the pharmaceutical aversiveness of active pharmaceutical ingredient (API) by administering the API after or substantially simultaneously with a flavone compound.  
WO/2021/051015A1
The inventions relate to the use of anti-hemichannel compounds, including anti-connexin 43 hemichannel opening compounds, to rescue or restore retinal function, to rescue or restore retinal structure, and/or to rescue or restore choroida...  
WO/2021/035342A1
Disclosed herein is a method for converting tetrahydrocannabinolic acid (THCA) to cannabinolic acid (CBNA). The method comprises contacting an input material comprising THCA with a benzoquinone reagent under reaction conditions comprisin...  
WO/2021/035344A1
Disclosed herein is a method for upgrading a cannabinoid mixture that comprises tetrahydrocannabinol (THC) and one or more non-THC cannabinoids, when the cannabinoid mixture has a THC content of less than about 20 wt. %. The method compr...  
WO/2021/040203A1
Salts and a crystal form of a compound in chemical formula 1, namely 2-(2,5-difluorophenyl)-3- carboxy-7-chloro-(4H)-4-benzopyranone, according to the present invention are excellent in terms of various physicochemical properties, namely...  
WO/2021/041637A1
Various aspects of this patent document relate to cannabinoid ions that are dissolved in glycerol, in which the cannabinoid ions are not carboxylates.  
WO/2021/035340A1
Disclosed herein is a method of converting a THC-rich cannabinoid mixture that comprises at least about 20 % THC into a CBN-rich cannabinoid mixture that comprises at least about 2.0 % CBN. The method comprises contacting the cannabinoid...  
WO/2021/038889A1
The present invention provides novel methods for producing a compound represented by formula (I) and either a compound represented by formula (B), which is an intermediate of the compound of formula (I), or a salt thereof.  
WO/2021/041107A1
The current invention is in the field of molecular biology/pharmacology and provides novel 3-oxabicyclo [3.3.1] nonene compounds and derivatives that modulate the effects of the classical estrogen receptors alpha and beta (ERalpha and ER...  
WO/2021/039023A1
The present invention provides, inter alia, a novel method for producing a compound represented by formula (I) and a novel method for producing a compound represented by formula (B) or a salt thereof, which are intermediates in the produ...  
WO/2021/030913A1
The present disclosure relates to cannabinoid compositions that are rehydratable and that upon such rehydration retain at least some of the properties of the original cannabinoid emulsions from which the cannabinoid composition was obtai...  
WO/2021/032643A1
The present invention relates to a compound of the general formula I and the pharmaceutically acceptable salts thereof; where the variables are as defined in the claims and the description. The invention also relates to the compounds of ...  
WO/2021/034089A1
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device including the organic electronic element. According to the present invention, an organic el...  
WO/2021/031622A1
Disclosed is a method for extracting and separating dihydromyricetin from Ampelopsis grossedentata tea, belonging to the technical field of natural medicine extraction and separation. The specific steps are as follows: 1) weighing Ampelo...  
WO/2021/028810A1
The present invention relates to certain compounds, their use in therapy, as well as to pharmaceutical compositions including said compounds. Specifically, the invention relates to certain compounds and pharmaceutical compositions includ...  
WO/2021/025162A1
A compound represented by formula (1) (wherein L1 and L2 are given linking groups and Ar1 is a monovalent group having a structure represented by formula (2)).  
WO/2021/026257A1
Described herein are compounds and pharmaceutical compositions containing such compounds which are prodrugs of ALOX-15 inhibitors. Also described herein are methods for using such compounds in the treatment of disease.  
WO/2021/025444A1
Despite various functions discovered of polyphenol-based compounds in regulating biological responses, such compounds, due to difficulty in procuring same in sufficient amounts with a high enough purity to permit application in pharmaceu...  
WO/2021/025163A1
This organic electroluminescence element has a negative electrode, a positive electrode, and an organic layer between the negative electrode and the positive electrode, wherein the organic layer contains a compound represented by formula...  
WO/2021/022378A1
The current application relates to a composition comprising a cannabis extract and a lipid-based carrier; wherein the lipid-based carrier comprises omega-3 fatty acids and at least one of monoacylglycerides, diacylglycerides, triglycerid...  
WO/2021/020481A1
The present invention is a method for producing an intermediate of iguratimod derivatives, a method for producing iguratimod, iguratimod having a novel crystal structure, and a method for producing the same. The present invention can rai...  
WO/2021/021632A1
The present disclosure relates to the preparation of synthetic cannabinol and homologs thereof having the structure of Formula (I), wherein, n is 1, 2, 3 or 4. The methods described herein provide for high yields and purity in a one-pot ...  
WO/2021/016717A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a mixing vessel, a volatizing unit, and a distillation unit. The mixing vessel combines a first in...  
WO/2021/016720A1
The present technology generally relates to a triploid Cannabis plant, triploid Cannabis seeds and to methods for generating such triploid Cannabis plant. The methods comprise crossing a tetraploid Cannabis plant with a diploid Cannabis ...  
WO/2021/018965A1
The present invention concerns compounds useful as modulators of sirtuins, in particular as SIRT1 activators. Moreover, the invention refers to the medical use of these compounds, in particular in the prevention and/or treatment of SIRT1...  
WO/2021/016716A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a first reaction vessel, a volatizing unit, and a distillation unit. The first reaction vessel pro...  
WO/2021/020788A2
The present invention relates to a method for synthesizing a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative. When the method is used, a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative can be effec...  
WO/2021/016718A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a volatizing unit, a fractional distillation unit, and a condensing unit. The volatizing unit rece...  
WO/2021/016280A1
The present disclosure provides certain tricyclic compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Also provided are pharmaceu...  
WO/2021/014229A1
The present invention relates to a compound of formula (I) or an enantiomer, to a pharmaceutically acceptable salt or solvate of this compound, or to a mixture thereof, wherein the core A, the substituents Z, Y and R1i are as defined in ...  
WO/2021/013931A1
The present invention relates to methods and means for inhibiting or preventing the growth of non-filamentous biofilm forming fungal cells with at least one flavone of formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are independently f...  

Matches 1 - 50 out of 15,187